A double-blind randomized clinical trial of a topical herbal extract (Z- HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran

International Journal of Dermatology

Volumn 38, Issue 8, 1999, Pages 610-612

  Zerehsaz, Fereidoun ^a,b   Salmanpour, Rahmat ^a   Handjani, Farhad ^a   Ardehali, Sadreddine ^a   Panjehshahin, Mohammad Reza ^a   Tabei, Seyed Ziaeddin ^a   Tabatabaee, Hamid Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; MEGLUMINE ANTIMONATE; PLACEBO; UNCLASSIFIED DRUG; Z HE;

ADOLESCENT; ADULT; AGED; ANGIOSPERM; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HERBAL MEDICINE; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; IRAN; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 0032774605     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00727.x     Document Type: Article

References (9)

1. Nadim A, Seyedi-Rashti MA. A brief review of the epidemiology of various types of leishmaniasis in Iran. Acta Medica Iranica 1971; XIV: 99-106.
2. Hatam GR, Hosseini SMH, Ardehali S. Dermotropic isolates of Leishmania infantum in Iran. Trans R Soc Trop Med Hyg 1997; 91: 440.
3. Moaddeb A, Gettner S, Ardehali S. Studies on the causative agent of cutaneous leishmaniasis in Shiraz, Iran. Iranian J Med Sci 1993; 18: 28-32.
4. Berman JD. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies. Rev Infect Dis 1988; 10: 560-586.
5. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-272.
6. Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol 1996; 14: 513-517.
7. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703.
8. Control of leishmaniases. Report of a WHO Expert Committee. Technical Report Series, 793. Geneva: WHO, 1990.
9. Alkhawajah AM, Larbi E, Al-Gindan Y, et al. Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration. Ann Trop Med Parasitol 1997; 91: 899-905.